Cancer

ATLANTA -- The investigational therapeutic umbralisib, which targets the molecule PI3K-delta, was well tolerated and highly active in patients with...

ATLANTA -- The anti-PD-1 monoclonal antibody pembrolizumab (Keytruda) showed promising antitumor activity with durable responses in patients with pretreated, advanced...

Data presented at AACR Annual Meeting on recently approved drug that targets common mutation in AML ATLANTA - An inhibitor...

Study results to be presented during a plenary session at AACR Annual Meeting ATLANTA - A new combination of immunotherapy...

ATLANTA --Excess weight before age 50 may be more strongly associated with pancreatic cancer mortality risk than excess weight at...

Computational tools seek to identify pancreatic cancer earlier, provide more opportunities for timely, effective treatmentsCredit: Pancreatic Cancer Collective (ATLANTA -...

Credit: Hope Foundation for Cancer Research A combination of two common immunotherapy drugs shrinks rare, aggressive neuroendocrine tumors, according to...

ATLANTA -- Adding the investigational MET inhibitor savolitinib to the EGFR inhibitor osimertinib (Tagrisso) yielded clinical responses in patients who...

ATLANTA -- A combination of the anti-CTLA-4 immunotherapeutic ipilimumab (Yervoy) and the anti-PD-1 immunotherapeutic nivolumab (Opdivo) showed clinical benefit among...

ATLANTA -- A combination of chemotherapy and chimeric antigen receptor (CAR) T cells designed to target the protein HER2 was...

ATLANTA -- A chimeric antigen receptor (CAR) T-cell therapy that targets the protein mesothelin showed no evidence of major toxicity...

An international collaboration led by St. Jude Children's Research Hospital reveals the genomic basis of acute erythroid leukemia, an aggressive...

Starting routine colorectal cancer screening at age 45 rather than 50 would decrease U.S. cancer deaths by as much as...

Credit: Joe Howell A medicine currently being tested as a chemoprevention agent for multiple types of cancer has more than...

Fungal infection is life-threatening to people with weakened immune systems, such as those with blood cancers, HIV infection or following...

A new study led by scientists in the Center for Cancer Research (CCR) at the National Cancer Institute (NCI) sheds...

Credit: Public domain Researchers at the RIKEN Center for Sustainable Resource Science (CSRS) in Japan have developed a new computational...

Credit: Mary Ann Liebert Inc., publishers New Rochelle, NY, March 28, 2019--Researchers have shown that cancer immunotherapy targeting the tumor...

Credit: CNIO Paragangliomas and phaeochromocytomas are very rare neuroendocrine tumours: there are only 3-8 cases per million inhabitants worldwide. They...

Credit: Rios, Visvader et al., Walter and Eliza Hall Institute - published in Cancer Cell Walter and Eliza Hall Institute...